(Q43066913)

13 November 2017

0 references

Hypoparathyroidism: is it time for replacement therapy? (English)

1 reference

13 November 2017

1 reference

Mara J Horwitz

1

1 reference

PMCID

2729233

13 November 2017

Andrew F Stewart

series ordinal

2

1 reference

PMCID

2729233

13 November 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

The Journal of Clinical Endocrinology and Metabolism

13 November 2017

1 reference

13 November 2017

93

1 reference

13 November 2017

9

1 reference

13 November 2017

3307-3309

1 reference

Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729233

Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729233

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729233

A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729233

On the interpretation of rat carcinogenicity studies for human PTH(1-34) and human PTH(1-84).

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729233

Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729233

A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729233

Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2729233

Translational implications of the parathyroid calcium receptor

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18772463

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18772463

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1210/JC.2008-1216

1 reference

13 November 2017

1 reference

13 November 2017

1 reference

PMCID

2729233